Mrm-ms - OmicsDI

Show results for

Unknown (522)
Proteomics (321)
Metabolomics (215)
Transcriptomics (8)
Genomics (6)
Other (5)
Multiomics (1)

Organisms

Homo sapiens (97)
Mus musculus (16)
Escherichia coli (3)
Bos taurus (3)
Arabidopsis thaliana (2)
Saccharomyces cerevisiae (2)
Gallus gallus (2)
Macaca fascicularis (2)
Mycobacterium tuberculosis (2)
Rattus norvegicus (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Burkholderia cenocepacia (1)
Euphorbia dendroides (1)
Bubalus bubalis (1)
Elephas maximus (1)
Loxodonta africana (1)
Loxodonta cyclotis (1)
Mammuthus primigenius (1)
Canis lupus familiaris (1)
Ebola virus (1)
Edwardsiella tarda (1)
H5N1 subtype (1)
Hordeum vulgare (1)
Human immunodeficiency virus 1 (1)
Influenza A virus (1)
Influenza B virus (1)
Labeo rohita (1)
Pseudomonas putida KT2440 (1)
Respiratory syncytial virus (1)
Rhodotorula toruloides (1)

Organisms

Mus musculus (2)
Ureaplasma parvum serovar 3 (1)
Haliotis discus hannai (1)

Repository

MetaboLights (203)
pride (140)
MassIVE (63)
PanoramaPublic (52)
jPOST (41)
PeptideAtlas (18)
GNPS (11)
iProX (8)
biostudies-arrayexpress (6)
ENA (6)
GPMDB (4)
geo (2)
NODE (1)

Tissue

Cell culture (27)
Blood plasma (23)
Blood serum (14)
Others (14)
Liver (14)
Brain (9)
Blood cell (7)
Epithelial cell (6)
Hepatocyte (6)
Permanent cell line cell (6)
Blood (5)
Heart (5)
Lung (5)
Dendritic cell (4)
Bone marrow (3)
Fibroblast (3)
Kidney (3)
Plant cell (3)
Saliva (3)
Breast cancer cell (2)
Colon (2)
Embryo (2)
Endothelial cell of umbilical vein (2)
Eye (2)
Follicular fluid (2)
HeLa cell (2)
Leaf (2)
Macrophage (2)
Pancreas (2)
Placenta (2)

Disease

Disease free (5)
Not Available (4)
Breast cancer (4)
Colon cancer (4)
Cardiovascular system disease (3)
Aortic valve stenosis (2)
COVID-19 (2)
Influenza (2)
Non-small cell lung carcinoma (2)
Osteosarcoma (2)
Severe COVID-19 (2)
Alpha thalassemia (1)
Amyotrophic lateral sclerosis type 1 (1)
Brain glioblastoma multiforme (1)
Cervix carcinoma (1)
Diarrhea (1)
Ehlers-Danlos syndrome classic type 1 (1)
Epilepsy (1)
FTDALS1 (1)
Female reproductive organ cancer (1)
Glaucoma (1)
Hepatocellular carcinoma (1)
Human immunodeficiency virus infectious disease (1)
Insulin dependent type diabetes mellitus uncontrolled with ketoacidosis (1)
Leigh disease (1)
Liver disease (1)
Loiasis (1)
Long COVID (1)
Malaria (1)
Mild cognitive impairment (1)

Technology Type

Mass spectrometry (141)
Mass Spectrometry (140)
SRM/MRM (78)
Mass spectrometry assay (63)
Shotgun proteomics (62)
SWATH MS (41)
Bottom-up proteomics (22)
Affinity purification coupled with mass spectrometry proteomics (13)
Data-independent acquisition (9)
Gel-based experiment (7)
Data-dependent acquisition (6)
All-ion fragmentation (5)
Chemical cross-linking coupled with mass spectrometry proteomics (5)
Top-down proteomics (5)
Mass spectrometry imaging (4)
NMR spectroscopy (3)
HDMSE (3)
MSE (3)
PAcIFIC (3)
RNA mass spectrometry (2)
DiaPASEF (1)

Instrument Platform

Q Exactive (23)
TripleTOF 5600 (11)
LTQ Orbitrap Velos (11)
LTQ Orbitrap (10)
LTQ Orbitrap XL (7)
Liquid Chromatography Tandem MS (LC-MS/MS) (6)
QTRAP 6500+ (4)
Instrument (4)
6495C Triple Quadrupole LC/MS (3)
MS:1000419 (3)
Q Exactive Plus (3)
6460 Triple Quadrupole LC/MS (2)
6490 Triple Quadrupole LC/MS (2)
Amazon SL (Bruker Daltonics amaZon series) (2)
MS:1000031 (2)
MS:1000044 (2)
Orbitrap Fusion (2)
TSQ Vantage (2)
Illumina HiSeq X (1)
7820 A GC-5977B MSD (Agilent instrument model) (1)
TSQ QqQ (1)
TripleTOF 4600 (AB SCIEX instrument model) (1)
4000 QTRAP (1)
6470A Agilent QQQ (1)
6546 Q-TOF (Agilent Technologies) (1)
Dionex instrument model (1)
Exactive Plus (1)
LTQ Orbitrap Elite (1)
MALDI Synapt G2-S HDMS (1)
Orbitrap Exploris 480 (1)

Publication Date

2026 (77)
2025 (66)
2022 (55)
2016 (53)
2021 (37)
2024 (36)
2020 (31)
2023 (31)
2017 (27)
2019 (26)
2015 (25)
2018 (20)
2014 (18)
2013 (7)
2010 (4)
2008 (3)
2012 (1)
2009 (1)
2011 (1)

UNIPROT ID/AC

A0A024RC46 (14)
A0A0A0MS51 (14)
A2BFH1 (14)
A5A3E0 (14)
A6NHL2 (14)
A6NHQ2 (14)
A6NNZ2 (14)
A8MTJ3 (14)
B2RPK0 (14)
B2RXF3 (14)
B3KML9 (14)
B3KT93 (14)
B4DHB3 (14)
B4DKM5 (14)
B4DL86 (14)
B4DPR2 (14)
B4DRV9 (14)
B4DY08 (14)
B4E3A4 (14)
B7Z9A0 (14)
B8ZZ43 (14)
B9VP19 (14)
C9JM50 (14)
C9JSZ1 (14)
D3DPU2 (14)
E7EX29 (14)
E9PAV3 (14)
E9PB61 (14)
E9PC52 (14)
E9PFP8 (14)

ENSEMBL ID

ENSG00000170477 (14)
ENSG00000247315 (3)
ENSG00000147251 (1)

CHEBI ID

CHEBI:15741 (36)
CHEBI:15428 (34)
CHEBI:18012 (34)
CHEBI:32816 (33)
CHEBI:16335 (30)
CHEBI:30769 (29)
CHEBI:16708 (27)
CHEBI:30915 (27)
CHEBI:17368 (27)
CHEBI:17568 (26)
CHEBI:16704 (26)
CHEBI:16856 (25)
CHEBI:16750 (25)
CHEBI:15891 (25)
CHEBI:17053 (24)
CHEBI:16027 (24)
CHEBI:16040 (23)
CHEBI:17154 (23)
CHEBI:15843 (23)
CHEBI:16015 (23)
CHEBI:17596 (23)
CHEBI:6650 (22)
CHEBI:28044 (22)
CHEBI:16865 (22)
CHEBI:16235 (22)
CHEBI:15940 (22)
CHEBI:17895 (22)
CHEBI:16828 (22)
CHEBI:16811 (21)
CHEBI:17724 (21)

Metabolite Name

Adenosine (29)
Hypoxanthine (26)
Guanine (24)
Adenine (23)
L-Alanine (22)
Uracil (22)
Guanosine (22)
L-Methionine (22)
L-Phenylalanine (22)
Inosine (22)
Succinic acid (21)
Uridine (21)
Creatine (21)
L-Leucine (21)
L-Cystine (20)
Thymine (20)
Fumaric acid (20)
Thymidine (20)
L-Isoleucine (20)
L-Tyrosine (20)
L-Proline (19)
L-Valine (19)
Glycine (18)
Betaine (18)
Spermidine (18)
L-Tryptophan (18)
L-Serine (18)
Xanthine (18)
Tryptamine (17)
Ornithine (17)

First Public Date

2025 (2)
2014 (2)
2026 (1)
2023 (1)

Classification

bacteria (1)

Modification

4-tetrahydrothiazine-3-carboxylic acid (2)

Study type

Transcription profiling by array (4)
RNA-seq of coding RNA (2)

Release Date

2022 (79)
2021 (68)
2020 (52)
2023 (46)
2019 (40)
2018 (35)
2024 (34)
2016 (28)
2017 (27)
2025 (24)
2015 (22)
2014 (17)
2009 (12)
2013 (12)
2010 (10)
2012 (8)
2026 (7)
2011 (6)
2008 (1)

Lab affiliation

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA (3)
Texas Tech University (3)
Analytical Chemistry Lab Fondazione Istituto Italiano di Tecnologia Via Morego 30, 16163 Genova Italy (2)
Analytical Chemistry, Department of Chemistry – BMC and Science for Life Laboratory, Uppsala University, Box 599, 751 24 Uppsala, Sweden (2)
Fred Hutchinson Cancer Research Center (2)
Infection and Immunity Program, Biomedicine Discovery Institute & Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia (2)
International Peace Maternity and Child Health Hospital (2)
Max Planck Institute for Molecular Genetics, Ihnestrasse 63-72, 14195 Berlin, Germany (2)
Moffitt Cancer Center (2)
Nanyang Technological University (2)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (2)
1. Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hong Kong 2. Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong 3. Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Hong Kong (1)
Aarhus university (1)
Academia Sinica (1)
Assistant Professor, Department of Ophthalmology, School of Medicine, Indiana University Indianapolis, IN, USA (1)
Associate Professor, Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hong Kong SAR (1)
Bertis Inc. (1)
Biology Department, Brookhaven National Laboratory, USA (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands (1)
Biosciences and Nutrition, Riedel Lab, Karolinska Institute, Sweden (1)
Biosciences and bioengineering Department, IIT Bombay (1)
Boston Children's Hospital (1)
Cambridge Centre for Proteomics, Cambridge Systems Biology Centre, Department of Biochemistry, University of Cambridge, Cambridge CB2 1QR, U.K. (1)
Cantonal Hospital St. Gallen, Switzerland (1)
Capital Normal University (1)
Caprion Proteomics Inc., 201 President-Kennedy Ave., Montreal H2X 3Y7, Quebec, Canada (1)
Cedars-Sinai Precision Biomarker Laboratories (1)
Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Moscow 121205, Russia Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec H3T 1E2, Canada; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, Quebec H3T 1E2, Canada (1)
Center for Proteomics and Metabolomics Leiden University Medical Center (1)
Center for Proteomics and Metabolomics, Leiden University Medical Center and Proteomics Centre, University of Victoria (1)

Tags

xref:PubMed:21448875 (2)
pathogen (1)
pathogen:bacterium (1)

Previous page
1 / 108
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 108
Next page

Sort by:

Relevance

Page size

Bridging Targeted (Zeno MRM-HR) and Untargeted (SWATH) LC–HRMS in a Single Run for Sensitive Exposomics

Traditionally, chemical exposure has been assessed by low-resolution mass spectrometry via targeted approaches due to the typically extremely low concentration of such compounds in biological samples. Nevertheless, untargeted approaches are now becoming a promising tool for a broader investigatio...

2025-08-28 | MTBLS10565 | MetaboLights

HST-MRM-MS: A Novel High-Sample-Throughput Multiple Reaction Monitoring Mass Spectrometric Method for Multiplex Absolute Quantitation of Hepatocellular Carcinoma Serum Biomarker

Absolute quantification of clinical biomarkers by mass spectrometry (MS) has been challenged due to low sample-throughput of current multiple reaction monitoring (MRM) methods. For this problem to be overcome, in this work, a novel high-sample-throughput multiple reaction monitoring mass spectrometr...

ORGANISM(S): Homo Sapiens

2020-02-23 | PXD040708 |

MS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration.

Not available

S-EPMC3331852 | biostudies-literature

Application of LC-MS/MS MRM to Determine Staphylococcal Enterotoxins (SEB and SEA) in Milk.

Not available

S-EPMC4848643 | biostudies-literature

Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples

Invasive ductal carcinoma (IDC) is the most common type of breast cancer and the leading cause of breast cancer related mortality. In the present study, metabolomic profiles of 72 tissue samples and 146 serum samples were analysed using targeted liquid chromatography multiple reaction monitoring mas...

2018-10-16 | MTBLS552 | MetaboLights

A Simplified Proteomics LC-MRM-MS Assay for Determination of apoE Genotypes in Plasma Samples.

Not available

S-EPMC11002930 | biostudies-literature

A Species-Specific Strategy for the Identification of Hemocoagulase Agkistrodon halys pallas Based on LC-MS/MS-MRM.

Not available

S-EPMC9196937 | biostudies-literature

Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients.

Not available

S-EPMC4302417 | biostudies-literature

Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).

Not available